SAN ANTONIO, July 09, 2025--bioAffinity Technologies' CyPath® Lung detects Stage 1A lung cancer when imaging was inconclusive ...

Medical experts report rising lung cancer diagnoses in non-smokers as smoking rates decline, raising questions about ...

Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had ...

This newly launched program can save lives, with the proportion of cases identified at an early stage expected to rise from ...

From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...

During a live event, Sumanta K. Pal, MD, discussed second-line renal cell carcinoma therapies, in the context of a patient ...

New guidelines confirm that for biomarker testing, navigation‑guided bronchoscopy yields lung tissue equal to that from ...

I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive ...

Lung cancer isn't just a smoker's disease. Discover the surprising truth about who else is at risk and why the numbers are rising in unexpected groups.

Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to lung adenocarcinoma cells, dramatically suppressing tumor growth in ...

Just ten days before, I’d undergone a robotic-assisted surgery to remove my right lower lung lobe to remove adenocarcinoma ..